About Us

dandelionRX is a public benefit corporation dedicated to finding innovative ways to improve how healthcare teams communicate the diagnosis of cancer, and treatment options to patients and caregivers.

We work with partners to develop training and other tools designed to help healthcare professionals overcome challenges when talking to patients about a difficult diagnosis and a complex treatment plan.

 
Matt_Olaveon.jpg

Matt Olaveson,


Director

Matt founded dandelionRX in 2019 believing there are better ways to help patients and caregivers navigate a diagnosis of cancer, plan for treatment, and find support. He is focused on finding solutions that improve outcomes and quality of life for patients living with chronic disease.

Matt has extensive experience in capital markets, market research and sales, working with strategy teams at corporations, with a particular focus on pharmaceutical, healthcare and manufacturing.

 
Katherine+Crawford-Gray.jpg

Katherine Crawford-Gray,
Project Lead

Katherine joined dandelionRX in 2020 to oversee the delivery of continuing medical education training and communication tools for healthcare teams to use with women diagnosed with ovarian or endometrial cancer.

She has been working in advocacy in women’s cancers over the last decade and is driven by the need to ameliorate inequities many people face in the U.S. in accessing the country’s healthcare system.

 
 

Ovarian and Endometrial Cancer
Project Advisors

 

Penny Daugherty,


RN, MS, OCN, ONN-CG

Northside Hospital Center, GA

Don S. Dizon,


MD, FACP, FASCO

Lifespan Cancer Institute & Rhode Island Hospital, RI

Sarah DeFeo,


MPA

Ovarian Cancer research Alliance, NY

 

Carolyn Taylor,


Founder and President

Global Focus on Cancer, NY

Sharyn N. Lewin,


MD, FACS, FACOG

Holy Name Medical Center, NJ

Monique Dawkins,

Ed. D

Association of Community Cancer Centers, MD

 

Ovarian and Endometrial Cancer
Project Partners

 

Greater Good Studio is a design firm dedicated to inclusive, people-centered social change. They use human-centered design, a problem-solving process grounded in empathy and iteration, to create tools and platforms that improve quality of life for marginalized people and groups.

Greater Good Studio intentionally designs every project to maximize ownership, implementation and impact by engaging end users at the start, i.e. patients, caregivers and healthcare professionals.

Greater Good Studio and dandelionRX are partners in creating tools to help healthcare teams better support people diagnosed with endometrial and ovarian cancer.

AKH is an accredited provider of continuing education for licensed healthcare professionals. Through its national accreditation status with the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), the American Association of Nurse Practitioners (AANP), Academy of General Dentistry (AGD PACE), and the Commission on Dietetic Registration (CDR), AKH is a respected provider of certified continuing education.

AKH and dandelionRX are partners in creating CME training to help oncology professionals identify and overcome communication barriers regarding diagnosis and treatment.

MATTER opened in February 2015 with 30 startup companies and has since grown to include hundreds of startup and growth stage companies from around the world, dozens of corporate partners and a diverse array of programs supporting healthcare entrepreneurship and innovation. Their partners represent every sector of healthcare.

MATTER’s non-profit and no-equity model provide their community with a neutral platform where entrepreneurs can come together with industry leaders, scientists and clinicians from across the globe to collaborate on developing next-generation healthcare and life sciences technologies.

MATTER and dandelionRX partners to ensure a sustainable infrastructure for our early projects.

 

Financial Supporter

 
 

Tesaro, a GSK company, provided an educational grant for the ovarian and endometrial cancer projects.